BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27587305)

  • 1. A rare case of concurrent signet-ring carcinoma of breast and microangiopathic hemolytic anemia.
    Lara K; Bae E; Park H; Hussain F
    J Surg Case Rep; 2016 Sep; 2016(9):. PubMed ID: 27587305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microangiopathic Hemolytic Anemia Is a Late and Fatal Complication of Gastric Signet Ring Cell Carcinoma: A Systematic Review and Case-Control Study.
    Lam R; Tarangelo N; Wang R; Horibe M; Grimshaw AA; Jain D; Haffar S; Bazerbachi F; Kunz PL; Li DK
    Oncologist; 2022 Sep; 27(9):751-759. PubMed ID: 35589098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Metastatic Signet Ring Cell Carcinoma Presented as Acquired Thrombotic Thrombocytopenic Purpura: A Case Report.
    Eisa N; Nasef K; Emarah Z; Fattah MMA; Shamaa S
    J Hematol; 2018 May; 7(2):72-75. PubMed ID: 32300416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microangiopathic hemolytic anemia as the first manifestation of metastatic signet ring cell carcinoma of unknown origin: a case report and review of literature.
    Shin SY; Park H; Chae SW; Woo HY
    Korean J Lab Med; 2011 Jul; 31(3):157-61. PubMed ID: 21779188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: case reports and review of the literature.
    Arkenau HT; Müssig O; Buhr T; Jend HH; Porschen R
    Z Gastroenterol; 2005 Aug; 43(8):719-22. PubMed ID: 16088769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic plasma exchange in gastric signet ring cell carcinoma presenting as microangiopathic hemolytic anemia: A rare case report.
    Candar O; Ekinci O; Merter M; Aslan M; Aras I
    J Clin Apher; 2022 Dec; 37(6):606-610. PubMed ID: 36125111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura.
    Malkan UY; Albayrak M; Ozturk HB; Reis Aras M; Saglam B; Dogan K
    Case Rep Oncol; 2020; 13(3):1368-1372. PubMed ID: 33442357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic Anemia of Malignancy: A Case Study Involving Signet Ring Cell Metastatic Breast Cancer with Severe Microangiopathic Hemolytic Anemia.
    Lee EH; Otoukesh S; Abdi Pour A; Nagaraj G
    Case Rep Oncol; 2019; 12(1):104-108. PubMed ID: 31043946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-related microangiopathic hemolytic anemia in patients with advanced gastric cancer: A retrospective single-center analysis.
    Berger AK; Allgäuer M; Apostolidis L; Schulze-Schleithoff AE; Merle U; Jaeger D; Haag GM
    World J Gastrointest Oncol; 2020 Nov; 12(11):1288-1295. PubMed ID: 33250961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic signet ring gastric adenocarcinoma presenting with microangiopathic hemolytic anemia.
    Ali N; Kamran N; Adil S; Pervez S
    Indian J Gastroenterol; 2007; 26(4):185-6. PubMed ID: 17986749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microangiopathic hemolytic anemia associated with metastatic breast cancer: case report and literature review.
    Takabatake D; Oishi K
    Springerplus; 2016; 5(1):684. PubMed ID: 27350919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microangiopathic hemolytic anemia caused by a signet-ring cell carcinoma of the intrahepatic bile duct.
    Younes R; Ponzo P; Marzano A
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):431-434. PubMed ID: 28927252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytologic diagnosis of signet-ring cell carcinoma of the breast.
    Kamiya M; Mizuguchi K; Yoshimoto M; Tanaka M; Motegi S; Matushima H; Ishizawa M; Nakamura K
    Acta Cytol; 1998; 42(3):650-6. PubMed ID: 9622682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Severe microangiopathic hemolytic anemia as first manifestation of a CUP syndrome. Rapid hematologic remission under polychemotherapy].
    Abdel Samie A; Sandritter B; Theilmann L
    Med Klin (Munich); 2004 Mar; 99(3):148-53. PubMed ID: 15024487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microangiopathic hemolytic anemia as an initial presentation of metastatic cancer of unknown primary origin.
    Lin YC; Chang HK; Sun CF; Shih LY
    South Med J; 1995 Jun; 88(6):683-7. PubMed ID: 7777893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic signet ring cell carcinoma of unknown primary origin: a case report and review of the literature.
    Al-Taee A; Almukhtar R; Lai J; Jallad B
    Ann Transl Med; 2016 Aug; 4(15):283. PubMed ID: 27570777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated gastric carcinoma in disguise-presentation as microangiopathic haemolytic anemia with bone marrow necrosis.
    Yesodharan J; Kuruvilla S; Parameswaran Kavitha K; Lilly M
    Transl Gastroenterol Hepatol; 2016; 1():6. PubMed ID: 28138574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure primary signet ring cell carcinoma breast: A rare cytological diagnosis.
    Sandhu J; Dubey VK; Makkar M; Suri V
    J Cytol; 2013 Jul; 30(3):204-6. PubMed ID: 24130416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microangiopathic hemolytic anemias (MAHA) in cancer. A case report and review.
    Nordström B; Strang P
    Anticancer Res; 1993; 13(5C):1845-9. PubMed ID: 8267391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signet-ring cell carcinoma of the breast with uterine metastasis treated with extensive cytoreductive surgery: a case report and brief review of the literature.
    Ertas IE; Sayhan S; Karagoz G; Yildirim Y
    J Obstet Gynaecol Res; 2012 Jun; 38(6):948-52. PubMed ID: 22486859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.